Replies to post #429341 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

And going 8 months back, one month after TLD we’d be back to $1.50 on baseless nonsense looking forward to getting Sawston MHRA certified in december. And dropping from there as usual.

I believe the amount of criminal acts going on in the manipulation against NWBO, is beyond incredible and no matter FDA cares or not, I’m very grateful LP seems to acknowledge the threat and takes precautions.

We shall find out soon enough.

[IkeEsq]

And I presume that the company can respond to misinformation once TLD is released?

Sure . . . if they have a peer-reviewed article to back them up. How did they do against years of attacks from AF and others? The ones that sent the stock from over $10 to under $0.20? People are reasonably skeptical about a company's positive pronouncements and a coordinated and well-funded attack can be devastating.

The question is, do you honestly want NWBO to spend a couple of years trying to fight off attacks instead of getting the BLA submitted, getting production ready, and getting everything else lined up for Approval and beyond?

The fact that the stock is at $0.75 right now has a fairly limited impact as long as they are not issuing shares to raise capital, something they have not been doing much of since data lock. The share price will take care of itself when they are able to present a compelling case with TLD backed by an independent review by peers in the field.